The Effects of a 6-week Pre-operative Administration of a Microbiome Modulator "WellBiome" Versus Placebo on Cardiac Surgical Outcomes and NHS Cost Savings.

Recruiting N/A Interventional Study
Cardiovascular Diseases (CVD) Cardiovascular Surgery
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
50 – 80
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
80 (estimated)
Sponsor
Hull University Teaching Hospitals NHS Trust · Government
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
More than 7.4 million people in the UK are currently waiting for surgery. Behind that number are real people-patients preparing mentally and physically for procedures ranging from joint replacements to major heart and abdominal operations. This research forms part of a broader strategy known as prehabilitation - preparing the body before surgery to improve outcomes afterward. For patients waiting…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
INCLUSION CRITERIA: * Aged 50-80 * BMI ≥ 25-40kg/m² * Waist circumference \>94cm (men) and 88cm (women) * HbA1c 42-58 mmol/mol (6.0-7.5 old HbA1c units) * No known intolerances to oligosaccharides and xylooligosaccharides * Be stable dose of cholesterol and blood pressure medication for 3 months * …
Contacts

James Philip Hobkirk, PhD

+44 (0) 7894 264660

james.hobkirk3@nhs.net

CONTACT